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Abstract
Background: Emerging evidence suggests that dietary soy and phytoestrogens can have beneficial effects on lipid and
glucose metabolism. We have previously shown that male mice fed from conception to adulthood with a high soy-
containing diet had reduced body weight, adiposity and a decrease in glucose intolerance, an early marker of insulin
resistance and diabetes.
Objectives: The purpose of this study was to identify the precise periods of exposure during which phytoestrogens and
dietary soy improve lipid and glucose metabolism. Since intrauterine position (IUP) has been shown to alter sensitivity to
endocrine disruptors, we also investigated whether the combination of IUP and fetal exposure to dietary phytoestrogens
could potentially affect adult metabolic parameters.
Methods: Male outbred mice (CD-1) were allowed ad libitum access to either a high soy-containing diet or a soy-free diet
either during gestation, lactation or after weaning. Adiposity and bone mass density was assessed by dual x-ray
absorptiometry. Glucose tolerance was assessed by a glucose tolerance test. Blood pressure was examined by the tail-cuff
system.
Results: Here we show that metabolic improvements are dependent on precise windows of exposure during life. The
beneficial effects of dietary soy and phytoestrogens on adiposity were apparent only in animals fed post-natally, while the
improvements in glucose tolerance are restricted to animals with fetal exposure to soy. Interestingly, we observed that IUP
influenced adult glucose tolerance, but not adiposity. Similar IUP trends were observed for other estrogen-related metabolic
parameters such as blood pressure and bone mass density.
Conclusion: Our results suggest that IUP and fetal exposure to estrogenic environmental disrupting compounds, such as
dietary phytoestrogens, could alter metabolic and cardiovascular parameters in adult individuals independently of adipose
gain.
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Introduction
During the perinatal period, a mammal is highly susceptible to
endocrine disruption. This can permanently alter essential cellular
functions, potentially leading to adult disorders such as infertility,
metabolic disorders and cancer. Although the fetal origin of some
reproductive disorders related to the exposure to man-made or
environmental endocrine disrupting chemicals (EDCs) is rather
well established, there are emerging data that suggest that these
compounds may act as ‘‘obesogens’’ [1].
Most EDCs are characterized by their capacity to mimic
estrogen actions. In humans, concerns about the fetal susceptibility
to exogenous estrogens (xenoestrogens) originated from the
findings that children from mothers who had been treated with
diethylstilbestrol (DES), a potent synthetic estrogen used during
pregnancy for the prevention of miscarriages, had higher risk of
developing cancer in reproductive organs [2,3,4]. Recent data
show that postnatal exposure to DES triggers obesity later in life,
suggesting that environmental compounds with estrogenic activity
may act as obesogens, and contribute to the current obesity
pandemic [5,6]. In addition, plant estrogens (phytoestrogens) such
as those found in soybean, modulate energy expenditure, adiposity
and glucose tolerance in rodents (for review see [7]). Evaluating
the extent to which environmental compounds positively or
negatively modulate metabolic features will significantly further
our understanding of the non-genetic origin of metabolic diseases.
The most important source of human exposure to phytoestro-
gens is the consumption of soy and soy-derived products, which
contain isoflavones - a class of phytoestrogens. Phytoestrogens
have the capacity of binding to both estrogen receptor (ER) a and
b, and to mimic estrogenic actions [8,9]. The conformation of the
receptor, and by inference its transcriptional response, is
dependent on the ligand, and in turn enables the recruitment of
various coregulators (coactivators or corepressors). As a conse-
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highly dependant on the ligand, its concentration, and on the
cellular context (cytoplasmic and nuclear environment).
Since both ERs are present in tissues responsible for the
regulation of metabolism (hypothalamus, adipose tissue, skeletal
muscle, b-cells, for review see [7]), the implication that
phytoestrogens regulate metabolism appears plausible. In this
direction, we have recently found that CD-1 male mice exposed to
high levels of dietary phytoestrogens from conception to adulthood
display a reduction of adiposity [10] together with an improve-
ment in glucose tolerance and insulin sensitivity due to an increase
in glucose uptake in skeletal muscles [11]. These findings indicate
that life-long exposure to dietary phytoestrogens improves
metabolic functions such as adiposity and glucose homeostasis.
However, little is known about the period during which cells
implicated in the regulation of metabolism are sensitive to
exposure to these compounds.
Numerous studies, most of which have focused on Bisphenol-A
(BPA), support the hypothesis that elevated levels of natural or
environmental estrogens during perinatal life may permanently
affect organ development, and thus result in a predisposition to
abnormal organ function or adult onset diseases [12]. It is
suggested that epigenetic patterns, which are transmitted from
mother to daughter cells during cell division or modified during
cell differentiation when transcription of particular genes is
permanently turned off or on, are irreversibly altered by the
exposure to environmental compounds [13]. Identification of the
time window during which an individual is more sensitive to EDCs
would provide important insights into the endocrine origin of
metabolic diseases. In addition, it would significantly improve
fundamental understanding of the mechanisms that lead to an
increased frequency of metabolic diseases.
We previously observed a decrease in adiposity and an
amelioration of glucose tolerance in male mice with life-long
exposure to phytoestrogens. We hypothesized that some of these
beneficial effects could result from an exposure restricted to
specific periods of life. Here, we found that the windows of
sensitivity to phytoestrogens that lead to the improvements in
adiposity and glucose tolerance do not overlap. The improvements
in adiposity occur in postnatal and adult life, whereas glucose
tolerance improvements are restricted to fetal exposure. In
addition, we provide evidence that the intrauterine position
(IUP), a model which consists of assessing in adulthood the effects
of minute changes in steroid levels during fetal life, determines
glucose tolerance, blood pressure and bone mass density in adult
individuals.
Results
Phytoestrogen exposure during different developmental
periods
To identify the period during which leanness or the improve-
ment in insulin sensitivity is acquired upon exposure to dietary
phytoestrogens, male mice were exposed to a soy-rich diet during
specific developmental periods (Figure 1A). Two groups, used as
a reference, were exposed from conception onwards either to a
phytoestrogen-rich diet (HP), or to a low phytoestrogen containing
diet (LP). This life-long exposure to LP or HP diets encompasses
the three major developmental periods (fetal, postnatal and adult),
as previously published [10,11]. Three additional groups were
generated: i) in utero exposure (HPiu), where pregnant females
consume the HP diet prior to and during the whole gestation. ii)
postnatal exposure (HPpn), where lactating mothers consume the
HP diet from birth until weaning so that the pups are exposed to
phytoestrogens throughout lactation and iii) chronic exposure
(HPch), where male pups are fed the HP diet from weaning
onward.
Fetal exposure to dietary soy improves glucose control,
but not adiposity
Different periods of exposure influenced body weight (ANOVA:
p,0.0001) and adiposity (p,0.0001). HP mice showed a
significant reduction in weight and adiposity when compared to
LP mice as previously shown [10]. Whereas in utero exposure to
dietary soy had no effect on body weight or adiposity, post-natal
exposure was sufficient to significantly reduce weight and adiposity
in comparison to life-long LP exposure (Figure 2A, B). This
effect was greater in chronically exposed mice (HPch), suggesting
that adulthood is the most sensitive period for adipose changes
triggered by dietary soy. The leanness and reduced adiposity was
even more pronounced in mice exposed throughout their lives (HP
mice), indicating that the post-natal and chronic effects may be
additive. These results suggest that the beneficial effects of
phytoestrogens on adiposity occur only after birth.
To investigate glucose tolerance, all mice were simultaneously
subjected to a glucose bolus (1 mg/kg) and glycemia also appeared
modulated by different periods of exposure (p,0.0024). For sake of
clarity, glucose tolerance is represented here as an area under
curve (AUC). As previously shown, HP mice displayed an
improvement in glucose tolerance [11]. Interestingly, the im-
provement in glucose tolerance is restricted to mice exposed to
dietary phytoestrogens during fetal life, whereas exposure after
birth had no statistical effect on glucose tolerance despite the
reduction in adiposity (Figure 2C). Notably, the effects of fetal
exposure to phytoestrogens did not reach the efficiency of lifelong
exposure. These results suggest that the improvement in glucose
homeostasis is set during fetal life, and that the beneficial effects on
adiposity and insulin sensitivity are disconnected and independent.
Fetal hormonal environment determines adult glucose
homeostasis
The human fetus is very sensitive to small hormonal changes.
For example, twins receive small amounts of sex hormones from
their neighboring sibling during fetal development. Adult sexually
dimorphic traits such as second to fourth digit finger ratio [14],
Figure 1. Schematic of the experimental design for period of
sensitivity experiments. (A) Experimental design for period of
sensitivity experiments. For in utero exposure (HPiu), male and females
were fed for 2 weeks prior to mating up until birth with the HP diet, at
which point the diet was replaced with the LP diet. For post-natal
exposure (HPpn), female mice were fed with the LP diet until
parturition, at which point the diet was shifted to the HP diet until
weaning (P21). For the chronic adult exposure (HPch), animals were
exposed to the HP diet only from weaning onwards. Male and female
pups were normalized for litter size at birth (n=11), with an equivalent
male to female ratio.
doi:10.1371/journal.pone.0007281.g001
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canine size [18] and reproductive fitness [19] will be influenced by
the gender of the developing neighbor. In rodents, the models that
enables to assess adult effects of minute changes of steroid levels
during fetal life is the intrauterine position model (IUP) [20]. Due
to the transfer of androgens and estrogens from adjacent fetuses
[21], female or male fetuses surrounded by two males (2M) have
higher amniotic or blood testosterone and lower amniotic or blood
estradiol than fetuses flanked by two females (2F) [22,23]. As a
consequence 2M animals exhibit more masculinized anatomical,
physiological and behavioral traits than 2F littermates (for review
see [20]). Thus, variability in hormone levels in rodent and human
fetuses has important ‘‘programming’’ consequences that can
impact adult physiology and disease.
Figure 2 suggested that fetal hormonal environment may
induce permanent changes in adult glucose homeostasis without
altering adiposity in mice. To test this hypothesis, we relied on the
IUP model. The uterine position of each individual was identified
just before birth to allow the comparison of adult phenotypes
according to their uterine environment. Animals were exposed
either to the LP or HP diet throughout life. In brief, male fetuses
were isolated by caesarean delivery a few hours before normal
parturition, the IUP was identified (2F, 1M, 2M), the fetuses were
marked so that their uterine position could be identified in
adulthood, and finally eleven male and female fetuses were
transferred to a foster mother. At 6 months of age, we assessed
body weight and adiposity (Figure 3A, B). As expected, HP mice
were significantly lighter in weight and leaner than LP mice
(p=0.0086 and p,0.0001 respectively). However these parameters
were not affected by the IUP since 2F, 1M and 2M mice exhibited
similar body weight and adiposity relative to the rest of their
group, for both the LP and HP groups. These results support our
initial findings (Figure 2) indicating that small changes in
hormonal environment during fetal development do not influence
adiposity later in life.
Fetal hormonal environment pre-determines the degree
of glucose intolerance
Interestingly, we found that IUP affects the glycemic control of
adults from both the HP and LP groups (p=0.0284) (Figure 3C,
D). Glucose intolerance was higher in 2M LP mice when
compared to 2F LP mice, suggesting that either fetal enrichment
with androgens decreases glycemic control or that higher estrogen
levels (here by two female embryos) improves glucose homeostasis.
Phytoestrogens are considered as pseudo-agonists, since their
activity depends on the level of natural estrogens. For instance,
their activity is low at physiological levels of estrogen (1 nM), such
as those found in pre-menopausal women, and it rises when levels
of estradiol are lower (0.01 nM), such as those found in post-
menopausal women [24]. Consistent with these pseudo-agonistic
Figure 2. Period of sensitivity for the effects of phytoestrogen exposure on adiposity and glucose metabolism. Body weight (A) and
adiposity (B) were lower only in animals exposed to the HP diet after birth. Improvements in glucose tolerance (C), represented as the mean-area-
under-curve of a glucose tolerance test (GTT), was restricted to the animals fed the HP diet during fetal life (HPiu). Results are mean6SEM (n=14-15);
*p,0.05, **p,0.01, ***p,0.001 versus LP.
doi:10.1371/journal.pone.0007281.g002
Figure 3. Influence of intrauterine position on adult male adiposity and glucose tolerance. Body weight (A) and fat abundance (B) were
lower in HP mice versus LP mice, but intrauterine position did not influence those parameters. Glucose intolerance was higher in 2M than in 2F male
mice in absence of phytoestrogens (C). Phytoestrogens drastically improved glucose tolerance in 2M male mice, but they had negligible effects in 2F
male mice (D). Results are mean6SEM (n=3-10), *p,0.05, **p,0.01, ***p,0.001 of HP groups vs LP groups.
doi:10.1371/journal.pone.0007281.g003
Glucose Tolerance in Mice
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phytoestrogens radically improved the glucose intolerance found
in 2M males, while it had no influence in 2F males (see Figure 4A,
which is an area under curve of Figure 3C, D). These findings
suggest that the IUP affects glucose tolerance and that minute
changes in estrogenic compounds can potentially trigger important
changes in adult glucose tolerance.
To reinforce these findings, we measured other estrogen-related
properties such as bone mass density (BMD) and blood pressure.
We found that IUP influences BMD (p=0.0014) with similar
trends and blood pressure to a lesser extend (p=0.2431),
suggesting that glucose control, BMD and blood pressure may
be hormonally predetermined during fetal life (Figure 4A-C).
Overall, it suggests that several metabolic parameters, with the
exception of the regulation of adipose mass, are pre-determined
during fetal life by endogenous hormones and by the exposure to
dietary phytoestrogens.
Discussion
The present findings demonstrate by two independent exper-
iments that, in addition to the nutritional and genetic predispo-
sitions, the degree of glucose intolerance is set during fetal life by
hormonal factors [i.e. environmental endocrine disrupting com-
pounds (EEDCs) and/or endogenous steroids] independently of
adipose gain. While we focused only on phytoestrogens as a
natural source of endocrine disruptors, our findings raise concerns
towards widespread synthetic compounds which activity can be
detected as low as parts per billion doses (e.g. Bisphenol-A, a high-
production-volume chemical used in the manufacture of polycar-
bonate plastic). In utero exposure to BPA at such low doses is known
to cause adverse health effects such as higher body weight,
increased breast and prostate cancer, and altered reproductive
function. Another natural source of steroids during fetal
development in humans is the maternal sex hormones. In humans,
the steroid levels during pregnancy are influenced by many factors
such as maternal age [25], parity [25], ethnic group [26] and
associated with an increased risk of testicular germ cell tumors,
prostate or breast cancer in the following generation . Further
investigation is needed to evaluate the relationship between
gestational exposure to EEDCs (e.g. Bisphenol-A, phtalates),
maternal and fetal steroid levels and subsequent metabolic effects
in adulthood.
An important question following from these findings is whether
the intrauterine position has significance for humans. Even though
IUP is usually considered in litter-bearing mammals where fetuses
are influenced by variable levels of steroids (androgens and/or
estrogens) due to the sex of neighboring fetuses, a similar situation
can be found in dizygotic (DZ) twins indicating that humans are
also sensitive to steroid influences by the neighboring embryo.
Male-female DZ twins show higher levels of sensation seeking (the
need for new and varied experiences through disinhibited
behavior) than do female DZ twins [27]. Otoacoustic emissions
(OAEs), which are continuous sounds produced by the cochlea,
are more frequent in females than in males. Interestingly, male-
female DZ twins have less OAEs than other female twins [15,28].
Finally, breast cancer predisposition appears to be increased in
female-female DZ twins when compared to male-female DZ twins
[29]. Although the proportion of DZ twins within the population is
on the rise, due to the increase use of in vitro fertilization
techniques, we believe that the most relevant consequences of
these findings extend to all singleton human fetuses and relate to
the effects of fetal hormonal environment on adult metabolism. By
hormonal environment, we mean the combination of both the
endogenous estradiol/androgens ratio and EDCs. These endo-
crine disruptors may be dietary phytoestrogens as described here
but could include other xenoestrogens, for example bisphenol A
and DES.
Our findings suggest that exposure to EDCs during the fetal
period could predetermine adult metabolic and cardiovascular
parameters. However, the precise molecular mechanism leading to
these alterations is currently unknown although epigenetic
modifications of gene expression by fetal exposure to phytoestro-
gens are a plausible hypothesis. Several years ago, Li et al [30]
demonstrated that fetal exposure to DES elicits demethylation of a
single CG site in the lactoferrin promoter with persistent
overexpression of the gene in mature mouse uteri. More relevant
to our study, the isoflavone genistein has been shown to alter
epigenetic marks in a model of adult-onset obesity [31], the yellow
agouti A
vy mouse, whose coat color and adiposity are dependant on
the methylation state of an intracisternal A particle (IAP)
Figure 4. Intrauterine position affects adult bone and vascular metabolism. (A) Bar graph of the area-under-curve (intolerance surface)
from the figure 3C, D. (B) Bone mass density according to the intrauterine position in LP and HP mice. (C) Influence of the intrauterine position on
blood pressure in LP and HP mice. Black bars represent HP animals while empty bars symbolize LP animals. Red curves represent the GTT performed
on animals fed on a LP diet, and those from HP mice are shown with blue curves. Results are mean6SEM (n=3-10), *p,0.05, **p,0.01, ***p,0.001
between the linked groups.
doi:10.1371/journal.pone.0007281.g004
Glucose Tolerance in Mice
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this study, Dolinoy et al. revealed that fetal exposure to genistein in
A
vy mice modified the methylation state of this IAP resulting in
altered coat color and in decreased prevalence of adult obesity
[31] thus demonstrating that genistein actions in utero can lead to
methylation changes with phenotypic consequences.
Unfortunately, our experimental design presents significant
technical limitations that prevent us to investigate epigenetic
alterations based on the IUP and/or after exposure to dietary
phytoestrogen during the fetal period. This is mainly due to a
combination of parameters including the low doses of fairly weak
estrogenic chemicals coupled with subtle, late-onset multifactorial
phenotypes that are rarely fully penetrant. In addition, the use of
an outbred strain precludes epigenetic analyses. Assessing the
intra-uterine position (IUP) in mice requires females capable of
producing large litter size which is only possible with outbred
strains (e.g. CD-1). This need is linked with technical and
experimental reasons: the IUP is determined after caesarean
delivery a few hours prior birth, and pups have then to be
transferred to a foster mother. More importantly, the two pups
located at both extremities of each uterine horn are eliminated and
only male pups in between are selected for IUP analysis. Thus,
small litter size, such as that of inbred strains, drastically reduces
the chances of obtaining 2F or 2M mice. To circumvent the
limitations of genetic variability, we attempted numerous times to
recapitulate our IUP analyses with a C57/B6 inbred strain but
failed, simply due to the difficulty of obtaining enough 2M and 2F
male mice for subsequent metabolic analysis. Finally, identifying
the epigenetic modulations caused by the fetal exposure to dietary
phytoestrogens or the IUP would require first to identify which
organs/tissues are responsible for the changes in glucose tolerance
without changes in lipid abundance through physiological and
molecular characterizations. Only then, a thorough epigenetic
analysis which includes whole-epigenome profiles combined with
transcriptome analyses could be undertaken.
Very few studies have evaluated the effects on metabolism of in
utero exposure to environmental compounds. Usually, these studies
are restricted to glucocorticoid overexposure (i.e. dexamethasone,
or due to maternal stress) during gestation and intrauterine growth
retardation, both known to program adult onset disorders such as
cardiovascular diseases (hypertension), and metabolic (i.e. hyper-
glycemia, hyperinsulinemia), endocrine and behavioral disorders
[35,36]. For instance, maternal stress during gestation leads to
adult glucose intolerance [37]. The placental 11b-hydroxysteroid
dehydrogenase type 2 is known to protect the fetus from maternal
glucocorticoids. Inhibition of this enzyme during fetal life of rats
leads to a decrease in body weight and glucose intolerance in
adulthood [38], an effect that is restricted to late gestation [39].
Thus, interference with the function of this enzyme and
glucocorticoid sensitivity might lead to increase risk of developing
adult diseases. A rise of testosterone levels during fetal life is
observed after maternal stress, suggesting that fetal androgens may
also be implicated in such diseases. Although the levels of
testosterone were not measured in the studies mentioned here,
several reports using the IUP model have shown that pregnant
mice subjected to intense light and heat during the final third of
gestation have increased serum corticosterone levels [40]. This
leads to an increase in testosterone levels in 2F male fetuses such
that that they behaved as 2M males in adulthood [41,42]. Why 2F
males are more sensitive to glucocorticoids is still unknown.
Nonetheless, 2M males exhibit behaviors that resemble those of 2F
exposed to glucocorticoids. Overall, these studies are consistent
with the present work, showing that 2M males are more prone to
develop diabetes and hypertension than are 2F males.
The effects observed upon exposure to dietary phytoestrogens
are consistent with the described pseudo-agonistic properties of
these compounds. The effects on glucose tolerance, bone mass
density and hypertension are greater in 2M males, were estradiol
levels are lower than in 2F males, leading to impressive changes.
This raises questions as to whether the effects of IUP are due to
either estrogenic (or anti-androgenic) or androgenic (or anti-
estrogenic) actions. The complexity of the dual roles played by
both estrogens and androgens is illustrated by studies in mouse
models lacking either the androgen receptor (ARKO) or the
estrogen receptor alpha (ERaKO). While one would expect
differing phenotypes, increases in weight gain and adiposity,
glucose intolerance, and insulin insensitivity, are observed in both
AR deficient and ERa deficient mice [43,44,45,46]. Adult
phenotypes resulting from specific intrauterine positions should
thus be regarded as complex estrogen-androgen interactions.
Bone mass density is tightly regulated by both male and female
hormones [47]. The decrease in bone mass density observed in
adult 2F LP males or in 2M HP males may indicate a
predisposition to osteoporosis due to the presence of fetal
estrogens. In females, estrogen is required for the modeling of
trabecular bones via ERa [48]. In contrast, studies using androgen
receptor and estrogen receptor alpha double knock-out mice (AR-
ERaKO) have shown that androgen, but not estrogen, actions are
required for the modeling of trabecular bone in males. Conversely,
the modeling of cortical bone requires the additive effects of both
androgens and estrogens [47]. Further studies will be required to
elucidate whether the microarchitecture, such as trabecular or
cortical bone volume and thickness, and the stiffness are affected in
order to understand the hormonal origins of the decreased BMD
in 2F males. It is interesting to note that genetic factors influence
bone mass density in humans as much as 85% [49]. Recently,
epidemiological evidence has suggested that there are correlations
between fetal and post-natal life, and fracture risk in adulthood
[50,51]. In most cases, the fetal origins of osteoporosis are due to
undernourishment during embryonic life [52]. Our observations
suggest that, in addition to nutritive factors and genetics, adult
BMD can also be influenced by fetal endocrine cues.
Studying EDCs is a difficult task. For practical purposes, we
used CD-1 mice due of their excellent reproductive characteristics
(11.5 pups per litter). Unfortunately, because of the mixed genetic
background of CD-1 mice, genetic and epigenetic analyses are
precluded. However, this model may prove useful in studying the
consequence of multiple ED exposure in utero on adult metabolic
and cardiovascular parameters. The IUP may serve as a tool to
directly influence sensitivity to a mixture of EDs, and would
therefore allow the assessment of whether these exogenous
molecules act in an additive or synergistic fashion to modulate
adult metabolic parameters.
Materials and Methods
Diets and animal care
CD-1 mice had ad libitum access to either a high soy-containing
[high phytoestrogen (HP)] diet (Harlan Teklad 8604; Harlan
Teklad, Madison, WI, USA], or a soy-free [low phytoestrogen
(LP)] diet (Zeigler Phytoestrogen Reduced Rodent Diet I; Zeigler
Brothers, Gardner, PA, USA). The isoflavone content of these two
closed-formula diets is approximately 355 ppm daidzein and 389
ppm genistein equivalents in the HP diet and nondetectable in the
LP diet (Analysis performed by Lareal, Vannes, France). These
concentrations of isoflavones are consistent with a soy protein
content of approximately 25% in the HP diet. Animals fed with
the HP diet had serum isoflavone levels of 0.3 mM (genistein or
Glucose Tolerance in Mice
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barely detectable [10,11]. Both diets are equivalent in terms of
carbohydrate, protein, fat, amino acid, vitamin, and mineral
content [53]. In the LP diet formulation, soy was omitted and
replaced by lactic casein and dried skim milk. The gross energy
content (1,626 mJ/100 g for the HP diet versus 1,668 mJ/100 g
for the LP diet), the metabolizable energy (3,100 vs. 3,240 kcal/
kg), and the digestable energy (3,300 vs 3,530 kcal/kg) were similar
for both diets. CD-1 male and female mice were purchased from
Charles River (Arbresle, France) for breeding. Animal protocols
used in these studies were approved by the Commission d’Ethique
de l’Expe ´rimentation Animale of the University of Geneva
Medical School and the Geneva Veterinarian Office. Animals
were treated humanely and with regard for the alleviation of
suffering. Mice were housed in polystyrene instead of polycarbon-
ate cages to avoid potential contamination with bisphenol-A, a
well-known endocrine-disrupting compound with estrogenic
activity.
Body composition determination
Peripheral dual energy x-ray absorptiometry (pDXA; PIXImus,
GE-Lunar Corp., Madison, WI, USA) was used to measure in vivo
percent fat mass of mice as previously described [10].
Glucose tolerance test
For glucose tolerance tests (GTTs), animals fasted overnight
(11 h) were injected intraperitoneally with 1.5 g glucose/kg body
wt. Plasma glucose levels were measured at 0, 30, 60, 90, and 120
min with Glucometer DEX (Bayer) as described in [11].
Blood pressure measurements
Tail cuff systolic blood pressure was measured in mice using a
noninvasive computerized tail cuff system (BP-2000, VisiTech
Systems, Apex, NC; [54,55,56]. Mice were trained for 1 week, and
then systolic and diastolic blood pressures were measured as the
mean of at least 15 to 20 successful measurements.
Statistical analysis
Results are expressed as means6SE of n experiments. ANOVA
or the nonparametric unpaired t test was used for statistical
analysis when appropriate. Differences were considered statisti-
cally significant if P was ,0.05.
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